JPRN-UMIN000050027已完成未知
Effectiveness and safety of Satralizumab in Japan; Interleukin-6 receptor inhibition in Neuromyelitis Optica Spectrum Disorders, multicentre medical chart review - SAkuraBeyond
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 7years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Any previous treatment with IL-6 inhibitory therapy except satralizumab.
研究者
相似试验
进行中（未招募）
不适用
Safety and Efficacy Study of BP-DPC18 for the treatment of Femoropopliteal Artery Lesions in Japaatherosclerotic diseaseJPRN-jRCT2072200103Soga Yoshimitsu120
已完成
不适用
Efficacy and Safety of Low Dose Prasugrel in Japanese Acute Coronary Syndrome Patients: A Single-center Prospective Clinical TrialAcute Coronary SyndromeJPRN-UMIN000019164Kurashiki Central Hospital250
已完成
2 期
Safety and Efficacy Study of Sorafenib in Japanese Child-Pugh A and B Patients with Advanced Hepatocellular CarcinomaAdvanced Hepatcellular CarcinomaJPRN-UMIN000004215Chiba University Hospital100
已完成
不适用
Clinical outcome of pazopanib in Japanese patients with soft tissue sarcoma; Multicenter studyMalignant soft tissue tumorJPRN-UMIN000012561Japanese Musculoskeletal Oncology Group200
已完成
2 期
Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian CancerFallopian Tube CancerPrimary Peritoneal CancerOvarian CancerNCT03759587Takeda19